Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Hydroxyprogesterone caproate, sold under the brand name Delalutin among others, is a medication used to reduce the risk of preterm birth in women pregnant with one baby who have a history of spontaneous preterm birth. In March 2023, the manufacturer, Covis Pharma, agreed to withdraw the drug from the US market. The approval of this drug substance was…
History, Community, Culture & Applications
Explore the main themes, entities and connections around Hydroxyprogesterone caproate. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
caproate hydroxyprogesterone progesterone intramuscular women injection mg found used birth medication 17α-hydroxyprogesterone study also brand pregnant effects preterm activity name
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Hydroxyprogesterone caproate | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Hydroxyprogesterone caproate | ATC code | G03DA03 (WHO) G03FA02 (WHO) | 1.00 | infobox |
| Hydroxyprogesterone caproate | Bioavailability | Oral: Very low (~3% in rats) Intramuscular: 100% (in rats) | 1.00 | infobox |
| Hydroxyprogesterone caproate | CAS Number | 630-56-8 Y | 1.00 | infobox |
| Hydroxyprogesterone caproate | ChEBI | CHEBI:5812 | 1.00 | infobox |
| Hydroxyprogesterone caproate | ChEMBL | ChEMBL1200848 | 1.00 | infobox |
| Hydroxyprogesterone caproate | ChemSpider | 148552 Y | 1.00 | infobox |
| Hydroxyprogesterone caproate | CompTox Dashboard (EPA) | DTXSID6043915 | 1.00 | infobox |
| Hydroxyprogesterone caproate | Drug class | Progestogen; Progestin; Progestogen ester; Antigonadotropin | 1.00 | infobox |
| Hydroxyprogesterone caproate | DrugBank | DB06789 Y | 1.00 | infobox |
| Hydroxyprogesterone caproate | ECHA InfoCard | 100.010.127 | 1.00 | infobox |
| Hydroxyprogesterone caproate | Elimination half-life | Non-pregnant: 7.8 days Singlet: 16–17 days Twins: 10 days | 1.00 | infobox |
| Hydroxyprogesterone caproate | Excretion | Feces: 50% Urine: 30% | 1.00 | infobox |
| Hydroxyprogesterone caproate | Formula | C27H40O4 | 1.00 | infobox |
| Hydroxyprogesterone caproate | KEGG | D00949 | 1.00 | infobox |
| Hydroxyprogesterone caproate | Legal status | US: withdrawn | 1.00 | infobox |
| Hydroxyprogesterone caproate | Metabolism | Reduction and hydroxylation (via CYP3A4, CYP3A5, CYP3A7) and conjugation (glucuronidation, sulfation, acetylation) | 1.00 | infobox |
| Hydroxyprogesterone caproate | Molar mass | 428.613 g·mol−1 | 1.00 | infobox |
| Hydroxyprogesterone caproate | Other names | OHPC; Hydroxyprogesterone capronate; Hydroxyprogesterone hexanoate; 17α-Hydroxyprogesterone caproate; 17α-OHPC; 17-Hydroxyprogesterone caproate; 17-OHPC; 17-HPC; 17α-HPC; HPC; L… | 1.00 | infobox |
| Hydroxyprogesterone caproate | Protein binding | Extensive (to albumin, not to CBGTooltip corticosteroid-binding globulin or (likely) SHBGTooltip sex hormone-binding globulin) | 1.00 | infobox |
| Hydroxyprogesterone caproate | PubChem CID | 169870 | 1.00 | infobox |
| Hydroxyprogesterone caproate | Routes of administration | Intramuscular injection, subcutaneous autoinjection | 1.00 | infobox |
| Hydroxyprogesterone caproate | Trade names | Delalutin, Proluton, Makena, others | 1.00 | infobox |
| Hydroxyprogesterone caproate | UNII | 276F2O42F5 | 1.00 | infobox |
| Hydroxyprogesterone caproate | is a | progestin medication which was used to prevent preterm birth in pregnant women with a history of the condition and to treat gynecological disorders | 0.90 | text |
| Hydroxyprogesterone caproate | is a | progestin | 0.90 | text |
| Hydroxyprogesterone caproate | is a | much more potent progestogen than 17α-hydroxyprogesterone | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.